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ABSTRACT
Objectives: Gestational diabetes mellitus (GDM) is described as a glucose intolerance of variable severity which begun or 
was firstly recognized during gravidity. Two major metabolic disorders, insulin resistance and β-cell dysfunction, currently 
play major role in pathogenesis of GDM. Our intention was to investigate total serum homocysteine and vitamin B12 levels 
in pregnant women with GDM and non-diabetic gravid women.
Material and methods: Serum homocysteine and vitamin B12 levels were prospectively measured in a total of 79 pregnant 
women, 60 of whom were diagnosed with GDM, and 19 of whom were healthy controls. Serum homocysteine levels were 
analyzed by ELISA. Vitamin B12 concentrations were determined by chemiluminescent immunoassay, and lipids were 
determined enzymatically.
Results: GDM and control groups did not differ in terms of the serum homocysteine levels (median 7.24 vs 7.97 umol/L, 
respectively, p = 0.15). Nor did we find any association between serum homocysteine levels and BMI (r = 0.06, p = 0.55, 
respectively). There was no correlation between serum homocysteine and fasting serum glucose (r = 0.3, p = 0.8, respectively). 
There was no relationship between serum homocysteine concentrations and glycosylated hemoglobin (HgbA1c) levels 
(r = 0.06, p = 0.67, respectively). Serum vitamin B12 concentrations did not differ between the GDM and control groups 
(median 286 vs 262 pg/mL, respectively, p = 0.17). We found that levels of Vitamin B12 correlated inversely with fasting serum 
glucose concentrations (r = -0.44, p = 0.0009). Vitamin B12 concentrations increased along with LDL (r = 0.27, p = 0.043) and 
HDL (r = 0.38, p = 0.004) levels, however were inversely correlated with serum triglycerides (r = -0.34, p = 0.009).
Conclusions: GDM patients with low Vitamin B12 values tend to have higher fasting serum glucose and altered lipid 
profiles (high triglycerides, low HDL and LDL). In women with GDM, serum homocysteine levels are not associated with 
HbA1c level, fasting glycemia, or BMI.
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INTRODUCTION
Gestational diabetes mellitus (GDM) is a frequent com-
plaint that affects relatively 7–14% of pregnancies. GDM 
is specified as any degree of glucose intolerance with 
commencement or first diagnosis during gravidity [1, 2]. 
The prevalence of GDM depends to a high degree on the eth-
nicity of the patient and on the diagnostic criteria used [3]. 
Although adverse lifestyle factors (overnutrition and physi-
cal inactivity) contribute to obesity, a significant number of 
trials connect early-life nutrient imbalance with the develop-
ment of metabolic disorders in childhood and early adult-
hood. Maternal obesity is characterised by the existence of 
an enormous amount of adipose tissue (AT) and negative 
effects on maternal wellbeing and the developing fetus, 
leading to cardiometabolic syndrome in children later in 
life [4].
In humans, homocysteine is formed during the methio-
nine metabolic cycle. The re-methylation of homocysteine 
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would not be possible without the enzyme methionine syn-
thase (MS) with which vitamin B12 is a co-factor and methyl-
tetrahydrofolate (methylTHF) a substrate. This process is indi-
rectly controlled by the activity of the enzyme methylenetet-
rahydrofolate reductase (MTHFR). Disturbances in the metab-
olism of homocysteine caused by the deficiency of co-factors 
or by some genetic enzyme defect, lead to cellular accumula-
tion of homocysteine which consequently elevates plasma 
homocysteine levels [5]. Compared with concentrations in 
nonpregnant women, serum homocysteine has been found 
to reduce during each trimester of gravidity (due to either 
a physiological answer to the pregnancy, an increase in estro-
gen, hemodilution from an elevated plasma volume, or en-
larged demand for methionine by both women and fetus) [6]. 
Elevated homocysteine concentrations during pregnancy 
are associated with an increased incidence of spontaneous 
abortion, intrauterine growth restriction, placental infarction, 
neural tubes defects and pre-eclampsia. Some researchers 
showed that hyperhomocysteinemia was associated with ear-
ly pregnancy losses and adverse pregnancy outcomes. [7–9]. 
When it comes to studies about plasma homocysteine levels 
and glucose tolerance in both diabetic and non-diabetic 
gravid women, it has also been shown that there is an associa-
tion between hyperhomocysteinemia and insulin resistance.
Vitamin B12 deficiency in pregnant women is increas-
ingly popular, and in many studies there has been shown 
association with higher body mass index (BMI) [10, 11], 
as well as with insulin resistance (IR), gestational diabetes 
(GDM), and type 2 diabetes (T2D) in future [12, 13].
B12 plays crucial role in the synthesis of methionine, the 
precursor of S-adenosyl-methionine (SAM), which is a major 
methyl donor for DNA methylation [13, 14].
MATERIAL AND METHODS
Based on these premises, we studied potential rela-
tionship between serum homocysteine and B12 levels in 
pregnant diagnosed with gestational diabetes mellitus 
compared with those with normal glucose tolerance. Our 
analysis was performed in the Department of Obstetrics 
and Women’s Diseases of the Poznan University of Medical 
Sciences between August 2017 and July 2018. Research 
ethics approval was obtained before we begun the study 
and the informed consent was obtained in writing from 
all participating women. Subjects were qualified for the 
study if they did not smoke nor took any medication for 
at least 3 months before recruitment, did not report any 
vitamin deficiency or significant diseases, and had no his-
tory of cardiovascular disease or previous medical history 
of diabetes mellitus. Women in multiple pregnancies were 
debarred from the study.
The study population included 79 gravid women, 60 of 
whom were diagnosed with gestational diabetes and 19 of 
whom were healthy controls. In our department, we generaly 
screen our patients between 24 and 28 weeks of gestation 
unless they have any of the risk factors of obesity, insulin 
resistance, a family history of any glucose intolerance, or have 
given birth to a macrosomic baby. The diagnosis of our sub-
jects’ gestational diabetes mellitus was based upon the Inter-
national Association of Diabetes and Pregnancy Study Group 
(IADPSG) criteria [15, 16]. Body mass indices (BMIs) of the 
study population were calculated at first visit in pregnancy.
Statistical analysis
R programming language (version 3.4.1) was used for 
statistical analysis. The distribution was determined with the 
Shapiro test. In case of normal distribution, the t-Student 
test (two-group comparison) or ANOVA (multigroup com-
parison) were applied. The sets with non-normal distribu-
tion were compared with the Mann-Whitney (two-group 
comparison) or the Kruskal-Wallis test (multiple groups co-
maprison). Linear relationships between parameters were 
determined by Pearson and Spearman correlation coef-
fcients for normal and non-normal data distribution, respec-
tively. The p values below 0.05 were considered significant. 
R packages (ggplot2, ggpubr) were used to generate plots 
(geom_boxplot() function) and add labels with applied sta-
tistics and p values (stat_compare_means() function). Data 
representing individual patients were visualised as dots in 
the boxplots. 
Blood samples 
We gathered 9 mL of blood for freezing and later testing. 
Specimens were immediately kept at 4 degrees Celsius and 
processed within 4 h to avoid cell lysis. Blood fractionation 
was carried out centrifuge at 2500 x g for 10 min, and 3–4 mL 
of the blood serum’s supernatant was removed and stored at 
-80 degrees Celsius. For homocysteine analysis, samples were 
determined by an enzymatic test using Cobas c501 analyzer. 
Vitamin B12 was analysed using electrochemiluminescent 
immunoassay (ECLIA) with a Cobas e601 analyser (Roche 
Diagnostics Poland). The inter assay coefficient of variation 
was 2% for plasma homocysteine, and for values above the 
reference range, 1.4–2%. However, the coefficient of variation 
for TB12 was 3.2–4.3%, and for values above the reference 
range, 3.8%. The reference range for vitamin B12 was 
197–771 pg/mL (2.5–97.5 percentile). On the other hand, 
the reference range for homocysteine was 12–15 umol/L 
(adults 15–65 years old). Serum glucose, cholesterol, 
triglycerides, and HDL cholesterol were determined 
using a Cobas c501 auto analyser (Roche Diagnostics 
Poland). Using enzymatic colourimetric assay, insulin was 
measured by the electrochemiluminescence method 
with a Cobas e601 analyser (Roche Diagnostics Poland). 
LDL cholesterol was calculated using the Friedewald formula.
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RESULTS
The age of patients in our study ranged from 22 to 
43 years old. The mean age of the patients with gestational 
diabetes mellitus (GDM) was 32, whereas in the control 
(Ctrl) group it was 33 years. The clinical characteristics 
of the patients are shown in Table 1. There was no dif-
ference in body mass index (BMI) between the groups. 
The mean gestational age of diabetic patients (33 weeks) 
was comparable to that of the healthy controls (34 weeks). 
The clinical characteristics of the subgroups based on BMI 
intervals is presented in Table 2.
The GDM and Ctrl groups did not differ in terms of serum 
homocysteine levels (median 7.24 vs 7.97 umol/L, respec-
tively, p = 0.15, Wilcoxon test, Figure 1A). Serum homocys-
teine levels did not correlate with BMI (Pearson correlation, 
r = 0.06, p = 0.55, Figure 1B) and nor did they differ across 
BMI intervals (p = 0.95, Kruskal-Wallis test, Figure 1C). Next, 
we tested whether serum homocysteine levels could reflect 
metabolic abnormalities in GDM patients. However, there 
was no association between serum homocysteine and fast-
ing serum glucose (Pearson correlation, r = 0.03, p = 0.8, 
Figure 1D). Similarly, there was no correlation between the 
serum homocysteine concentration and the glycosylated 
Table 2. The clinical characteristics of subgroups depending on 
BMI intervals
BMI < 20 20–24.9 25–29.9 30–34.9 > 35
Number of 
patients 2.00 14.00 17.00 19.00 6.00
Mean body 
mass [kg] 46.5 60.84 78.00 84.00 95.83
Homocysteine 
[umol/L] 6.63 7.35 7.18 7.41 7.35
B12 [pg/mL] 544.15 292.52 289.54 253.18 269.32
Mean glycemia 
[mg/dL] 92.5 103.5 104.38 107.21 102.16
HbA1c [mmol/L] 4.5 4.84 5.11 5.24 5.24
Fasting serum 
glucose [mg/dL] 70 84 92.88 92.05 91.66
Total 
Cholesterol 
[mg/dL]
299.5 254.22 256.06 219.58 209.08
HDL [mg/dL] 82.45 212.13 76.02 70.35 69.72
LDL [mg/dL] 179.65 122.3 127 95.40 94.06
TAG [mg/dL] 187.05 212.14 272.71 237.34 226.42
Delivery at term 1 8 10 11 4
Cesarean Section 0 6 7 8 4
Fetal weight at 
term [g] 3263 3459 3521 3341 3557
Table 1. Selected demographic and clinical data of women with 
gestational diabetes mellitus (GDM) and glucose tolerant pregnant 
women (control)
Parameter
GDM Control
Group (n = 60) Group (n = 19)
Age [years] 32.27 +/- 4.5 33.73 +/- 5.0
Weight [kg] 76.58 +/- 14.6 73.73 +/- 11.27
Height [m] 1.65 +/-0.06 1.62 +/- 0.06
BMI [kg/m2] 27.59 26.98 
Gestational age [weeks] 33.26 +/- 5.54 34.88 +/- 5.66
Number of previous 
pregnancies:  
1st pregnancy 26 (43.33 %) 7 (36.84%)
2nd pregnancy 20 (33.33%) 8 (42.11%)
3rd pregnancy 11 (18.33%) 2 (10.53%)
4rd pregnancy 3 (5.0%) 2 (10.53%)
Homocysteine [umol/L] 7.41 +/- 2.61 8.02 +/- 2.27
Vitamin B12 [pg/mL]
287.45 +/- 111.44 246.30 +/- 101.69
(215.0–321.30)* (160.30–309.20)*
Systolic Blood Pressure- 
SBP [mmHg] 108.33 +/- 8.87 113.42 +/- 10.14
Diastolic Blood Pressure- 
DBP [mmHg] 68.25 +/- 7.74 70.78 +/- 7.68
Previous GDM 3 (5.08%) 1 (5.2%)
Gestational Age at Birth 
[weeks] 38.89 +/- 1.59 37.53 +/- 2.87
Birth weight [g] 3385.00 +/- 492.64 3421.42 +/- 564.18
Gender:
Male 31.58% 50%
Female 68.42% 50%
* — median, interquartile range
Figure 1A. Serum homocysteine levels in patients with GDM and in 
Ctrl group
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hemoglobin (HgbA1c) level (Pearson correlation, r = 0.06, 
p = 0.67, Figure 1E).
Serum vitamin B12 did not differ between the GDM and 
Ctrl groups (median 286 vs 262 pg/mL, respectively, p = 0.17, 
Wilcoxon test, Figure 2A). Nor was serum vitamin B12 as-
sociated with BMI (Pearson correlation, r = -0.2, p = 0.08, 
Figure 2B), and it did not differ across BMI intervals (p = 0.74, 
Kruskal-Wallis test, Figure 2C). Next, we analyzed whether 
vitamin B12 levels were in any relationship to metabolic 
disturbances within the GDM group. We found that with 
increasing levels of Vitamin B12, fasting serum glucose 
concentrations were lower (Pearson correlation, r = -0.44, 
p = 0.0009, Figure 3A). Correspondingly, we determined that 
HgbA1c increased in relation to decreasing levels of Vitamin 
B12 (Pearson correlation, r = -0.36, p = 0.006, Figure 3B). 
We demonstrated that the Vitamin B12 level was also asso-
ciated with the lipid profile in patients with GDM. Vitamin 
B12 concentrations increased together with levels of both 
LDL (Pearson correlation, r = 0.27, p = 0.043, Figure 4A) and 
HDL (Pearson correlation, r = 0.38, p = 0.004, Figure 4B). 
Serum triglycerides were more likely to be elevated in GDM 
patients with lower vitamin B12 concentrations (Pearson 
correlation, r = -0.34, p = 0.009, Figure 4C). 
DISCUSSION
Gestational diabetes mellitus is one of the most frequent 
metabolic disorders complicating pregnancy. The patho-
physiology of GDM and type 2 diabetes involves abnormal 
Figure 1B. Serum homocysteine levels and BMI in GDM and Ctrl 
group
Figure 1C. Serum homocysteine levels and fasting serum glucose in 
GDM and Ctrl group
Figure 1D. Serum homocysteine and fasting serum glucose in GDM 
and Ctrl group
Figure 1E. Serum homocysteine concentration and the glycosylated 
hemoglobin (HgbA1c) in GDM and Ctrl group
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pancreatic insulin release and insulin resistance. The inflam-
matory markers, metabolic abnormalities and endothelial 
dysfunctions in GDM can make the pregnant woman suf-
fering from this pathology and her developing fetus much 
more prone to cardiovascular diseases [17].
One of the factors responsible for this condition is the 
level of homocysteine. It is proved that acute and chronic 
exposure to homocysteine shows adverse effects on b-cell 
metabolism and insulin secretion [18]. Homocysteine levels 
are influenced by factors, such as age, gender, duration 
of diabetes, body mass index, nicotine addiction, kidney 
failure, vitamin status and blood pressure, but also by envi-
ronmental and genetic factors.
In the meta-analysis of Gong et al., serum homocyst-
eine concentrations were higher among women with GDM 
than among the controls. The evidence was more consistent 
among women in the second trimester and for women older 
than 30 years of age. As a result of physiological decreases in 
albumin during pregnancy, as well as in association with folic 
acid supplementation, the serum concentrations of homo-
cysteine decrease during pregnancy [19, 20]. Surprisingly, 
in our study, we did not find significant differences in those 
results between the GDM and control groups. The minimum 
value of homocysteine in our GDM group was 3.59, while 
the maximum was 16.87. In the control group, however, 
the minimum value was 3.75 and the maximum value was 
Figure 2A. Serum vitamin B12 in patients with  GDM and Ctrl group
Figure 2C. Serum vitamin B12 and BMI intervals in GDM and Ctrl 
group
Figure 2B. Serum vitamin B12 levels and BMI in GDM and Ctrl group
Figure 3A. Serum vitamin B12 and fasting serum glucose 
concentrations in GDM and Ctrl group
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12.34. The small differences between the two groups prob-
ably result from the small population of the control group.
It has been proposed that B-vitamins may play crucial 
role in the pathogenesis of glucose intolerance because of 
their ability to regulate homocysteine synthesis [21]. Results 
of recent studies on concentrations of vitamin B12 and its in-
fluence on the occurence of gestational diabetes are incon-
sistent. In the Krishnaveni et al. [22] and Lai et al. [23] studies, 
it was shown that in a subpopulation of South Asian women, 
those with vitamin B12 deficiency were much more likely 
to develop GDM or type 2 diabetes mellitus (T2DM) over 
the course of a 5-year follow up period. Similar results of 
lower vitamin B12 concentrations among pregnant women 
diabetes in comparison with healthy controls, were pre-
sented in Seghieri’s study [24]. However, there are several 
European studies which did not show differences in folates 
and vitamin B12 concentrations between women with GDM 
and those in the control groups [25–27, 12].
CONCLUSIONS
So far there has been conducted much research on ma-
ternal carbohydrates and fats intake and its relation to the 
risk of developing GDM. It has been suggested that group 
B vitamins may play role in the pathogenesis of glucose 
intolerance thank to their ability to regulate synthesis of 
homocysteine. In other words, vitamin B12 deficiency in 
pregnancy is related with a higher risk of GDM and type 
2 diabetes mellitus. In women with GDM, we did not find 
Figure 3B. Serum vitamin B12 concentration and the glycosylated 
hemoglobin (HgbA1c) in GDM and Ctrl group
Figure 4A. Correlation between serum vitamin B12 concentration 
and LDL levels in GDM group
Figure 4B. Correlation between serum vitamin B12 concentration 
and HDL levels in GDM group
Figure 4C. Correlation between serum vitamin B12 concentration 
and HDL levels in GDM group
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any correlation between serum homocysteine levels and 
HbA1c, fasting glycemia or BMI. Conversely, vitamin B12 val-
ues are inversely associated with glycemic status and lipid 
profiles. We concluded that the better the glycemic status of 
pregnant women with diabetes, the higher the concentra-
tion of vitamin B12. We agree that in future, large prospec-
tive cohort studies are needed to verify this finding and to 
evaluate the potential predictive role of these parameters 
for gestational diabetes mellitus.
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